Hongjin Wang
发表
J. Lou,
Yu-Long Lan,
Xun Wang,
2018
.
B. Zhang,
Xiaochi Ma,
J. Lou,
2018,
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
Jianmin Zhang,
Yu-Long Lan,
Hongjin Wang,
2022,
Immunology.
Bo Zhang,
Xiaochi Ma,
J. Lou,
2018,
Cancer medicine.
Yu-Long Lan,
Shuang Zou,
Yan-Guo Sun,
2019,
Neurological Sciences.
Silencing LncRNA LOXL1-AS1 attenuates mesenchymal characteristics of glioblastoma via NF-κB pathway.
Li Li,
Hongjin Wang,
Lin-lin Yin,
2018,
Biochemical and biophysical research communications.
John Cowell,
Gentao Liu,
J. Cowell,
2013,
Oncology reports.
Yinghui Zhou,
Tao Han,
Zhifan Zuo,
2021,
Frontiers in Pharmacology.
Meilin Liu,
Danfeng Cai,
Honghe Liu,
2023,
Neuron.
Yu-Long Lan,
Shuang Zou,
Xun Wang,
2021,
Frontiers in Pharmacology.
T. Han,
Hengyu Li,
Guangrong Zheng,
2022,
Frontiers in Oncology.
R. Dowling,
B. Yan,
P. Mitchell,
2017,
Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.
Qiuyu Liu,
Shiyu Nie,
Ze Tang,
2023,
Hereditas.